Evidence map›Paper›PMID 26471152›Full record

ArticleAddiction (Abingdon, England)2015

How beneficial is vaping cannabis to respiratory health compared to smoking?

Donald P Tashkin

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Addiction (Abingdon, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 30 citations in OpenAlex.

  1. Trends in cannabis use among those with and without a cancer diagnosis according to state-level cannabis policy: findings from the PATH Study, Waves 1-5 (2013-2019).Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. A qualitative analysis of cannabis vaporization among medical users.Experimental and clinical psychopharmacology · 2019
    Article
  8. Cannabis-Associated Asthma and Allergies.Clinical reviews in allergy & immunology · 2019
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. US Epidemiology of Cannabis Use and Associated Problems.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Article
  14. Article
  15. Article
  16. What Should We Tell Our Patients About Marijuana (Integrative medicine (Encinitas, Calif.) · 2016
    Article
  17. Confirmation of the trials and tribulations of vaping.Addiction (Abingdon, England) · 2015
    Article
  18. Cannabis Vaping-Induced Acute Pulmonary Toxicity: Case Series and Review of Literature.Journal of investigative medicine high impact case reports
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Donald P TashkinDavid Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
University of California, Los Angeles · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While vaping cannabis reduces respiratory exposure to toxic particulates in cannabis smoke, the resultant reduction in clinically evident harms to lung health is probably smaller than that likely to result from substituting e-cigarettes for smoked tobacco due to the comparatively greater harms of tobacco than cannabis smoking to lung health.

Indexed as

Electronic Nicotine Delivery SystemsHarm ReductionVapingHumansMarijuana SmokingPerceptionRespiratory Tract DiseasesSmokingCannabischronic bronchitise-cigaretteslung injuryrespiratory healthvaping

Identifiers

PMID26471152
OpenAlexW1961722559

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.